Next-Generation Combination Products

2023 Combo Products Summit Agenda

session

November 29, 2023 @ 4:45 pm

5:30 pm

Moderators

Susan Neadle, Principal Consultant and President, Combination Products Consulting, LLC

Sandy Boyd, Independent Consultant

Speaker

Dan Groszmann, Director of Engineering, Amgen

Geoff Hamilton, Chief Executive Officer, Stemson Therapeutics

Steven Oh, Deputy Office Director, Office of Cellular Therapy and Human Tissue, Center for Biologics Evaluation and Research (CBER), FDA

James Wabby, Global Head, Regulatory Affairs (CoE) – Emerging Technologies, Devices, and Combination Products & Volwiler Senior Research Industry Fellow – Regulatory Science, Abbvie

Emerging innovations (like cell-gene therapy and regenerative medicine products) can provide cures for previously untreatable conditions, which will change the face of the industry. Join us as we look forward to these emerging technologies and discuss regulatory approaches to adapt to the fast-paced dynamics of technology evolution!

This conference IS co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. government.

2023 Combo Products Summit Agenda

session